AMRX Operating Cash Flow (Statement)
Amneal Pharmaceuticals Inc Class A · Operating Cash Flow (Statement)
AMRX Operating Cash Flow (Statement)
Latest reported$200.78Mperiod ending
AMRX TTM Cash from Operations ($234.19M → $200.78M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AMRX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 200,778,000 | |
| 303,859,000 | |
| 339,992,000 | |
| 327,755,000 | |
| 351,079,000 | |
| 306,917,000 | |
| 295,099,000 | |
| 312,844,000 | |
| 252,457,000 | |
| 201,455,000 | |
| 345,577,000 | |
| 186,462,000 | |
| 198,645,000 | |
| 84,469,000 | |
| 21,102,000 | |
| 107,655,000 | |
| 96,449,000 | |
| 170,037,000 | |
| 241,820,000 | |
| 284,517,000 | |
| 246,929,000 | |
| 478,103,000 | |
| 379,001,000 | |
| 222,154,000 | |
| 317,288,000 | |
| 159,141,000 | |
| 1,705,000 | |
| 312,245,000 | |
| 234,464,000 | |
| 114,791,000 | |
| 250,230,000 | |
| 55,844,000 | |
| 67,228,000 | |
| 191,808,000 | |
| 234,187,000 | |
| 205,296,000 |